Cargando…

The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats

The protective effect of aspirin against myocardial hypertrophy (MH) was studied. Model rats of pressure overload MH were prepared by abdominal aortic coarctation. Rats were randomly divided into the sham group (n = 9), MH model group (n = 9), and MH+aspirin group (n = 9), which was, respectively, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaolong, Wei, Minghui, Zhang, Haifeng, Fan, Xiaomei, Ma, Xiaochen, Liu, Jiaming, Xue, Mingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081624/
https://www.ncbi.nlm.nih.gov/pubmed/33969115
http://dx.doi.org/10.1155/2021/2043415
_version_ 1783685681046880256
author Wu, Xiaolong
Wei, Minghui
Zhang, Haifeng
Fan, Xiaomei
Ma, Xiaochen
Liu, Jiaming
Xue, Mingming
author_facet Wu, Xiaolong
Wei, Minghui
Zhang, Haifeng
Fan, Xiaomei
Ma, Xiaochen
Liu, Jiaming
Xue, Mingming
author_sort Wu, Xiaolong
collection PubMed
description The protective effect of aspirin against myocardial hypertrophy (MH) was studied. Model rats of pressure overload MH were prepared by abdominal aortic coarctation. Rats were randomly divided into the sham group (n = 9), MH model group (n = 9), and MH+aspirin group (n = 9), which was, respectively, divided into the 4-week group and 8-week group according to the time of intragastric administration. Arterial blood pressure and left ventricular mass index (LVMI) were measured. Changes in myocardial tissue structure were observed by HE staining, Masson staining, and reticular fiber staining. Cardiomyocyte apoptosis was detected by TUNEL assay. The levels of TNF-α, IL-10, TXA2, and PGI2 in myocardium and plasma were detected by ELISA. The arterial blood pressure in the MH model group was significantly higher than that in the 4- and 8-week sham groups, but that in the MH+aspirin group was significantly lower than that in the MH model group. At 4 and 8 weeks, the LVWI in the MH model group was significantly higher than that in the sham group, but it was significantly reduced after aspirin treatment. The myocardial cell hypertrophy was obvious, collagen fibers were proliferated, and reticular fibers were reduced in the 4- and 8-week MH model groups. Compared with the MH model groups, myocardial cells in the MH+aspirin groups were significantly reduced, the collagen fiber content was significantly reduced, and the reticular fiber content was increased. The apoptotic cardiomyocytes in the 4- and 8-week MH model groups were obviously increased. The apoptosis of myocardial cells in the MH+aspirin groups was obviously decreased. The TNF-α levels in the myocardial tissue of the 4- and 8-week MH model groups were significantly increased, while those of the MH+aspirin groups were significantly decreased. There was no significant change in the IL-10 level or PGI2 level at 4 weeks. At 8 weeks, the PGI2 level was significantly decreased in the MH model group while significantly increased in the MH+aspirin group. The TXA2 levels were significantly increased in the 4- and 8-week MH model groups and those in the 4- and 8-week MH+aspirin groups were significantly lower. Aspirin has an anti-inflammatory effect, can effectively reduce the expression of inflammatory factors, inhibit myocardial apoptosis, and has a certain protective effect against MH.
format Online
Article
Text
id pubmed-8081624
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-80816242021-05-06 The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats Wu, Xiaolong Wei, Minghui Zhang, Haifeng Fan, Xiaomei Ma, Xiaochen Liu, Jiaming Xue, Mingming Biomed Res Int Research Article The protective effect of aspirin against myocardial hypertrophy (MH) was studied. Model rats of pressure overload MH were prepared by abdominal aortic coarctation. Rats were randomly divided into the sham group (n = 9), MH model group (n = 9), and MH+aspirin group (n = 9), which was, respectively, divided into the 4-week group and 8-week group according to the time of intragastric administration. Arterial blood pressure and left ventricular mass index (LVMI) were measured. Changes in myocardial tissue structure were observed by HE staining, Masson staining, and reticular fiber staining. Cardiomyocyte apoptosis was detected by TUNEL assay. The levels of TNF-α, IL-10, TXA2, and PGI2 in myocardium and plasma were detected by ELISA. The arterial blood pressure in the MH model group was significantly higher than that in the 4- and 8-week sham groups, but that in the MH+aspirin group was significantly lower than that in the MH model group. At 4 and 8 weeks, the LVWI in the MH model group was significantly higher than that in the sham group, but it was significantly reduced after aspirin treatment. The myocardial cell hypertrophy was obvious, collagen fibers were proliferated, and reticular fibers were reduced in the 4- and 8-week MH model groups. Compared with the MH model groups, myocardial cells in the MH+aspirin groups were significantly reduced, the collagen fiber content was significantly reduced, and the reticular fiber content was increased. The apoptotic cardiomyocytes in the 4- and 8-week MH model groups were obviously increased. The apoptosis of myocardial cells in the MH+aspirin groups was obviously decreased. The TNF-α levels in the myocardial tissue of the 4- and 8-week MH model groups were significantly increased, while those of the MH+aspirin groups were significantly decreased. There was no significant change in the IL-10 level or PGI2 level at 4 weeks. At 8 weeks, the PGI2 level was significantly decreased in the MH model group while significantly increased in the MH+aspirin group. The TXA2 levels were significantly increased in the 4- and 8-week MH model groups and those in the 4- and 8-week MH+aspirin groups were significantly lower. Aspirin has an anti-inflammatory effect, can effectively reduce the expression of inflammatory factors, inhibit myocardial apoptosis, and has a certain protective effect against MH. Hindawi 2021-04-20 /pmc/articles/PMC8081624/ /pubmed/33969115 http://dx.doi.org/10.1155/2021/2043415 Text en Copyright © 2021 Xiaolong Wu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wu, Xiaolong
Wei, Minghui
Zhang, Haifeng
Fan, Xiaomei
Ma, Xiaochen
Liu, Jiaming
Xue, Mingming
The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
title The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
title_full The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
title_fullStr The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
title_full_unstemmed The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
title_short The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
title_sort protective effect of aspirin against myocardial hypertrophy in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081624/
https://www.ncbi.nlm.nih.gov/pubmed/33969115
http://dx.doi.org/10.1155/2021/2043415
work_keys_str_mv AT wuxiaolong theprotectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT weiminghui theprotectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT zhanghaifeng theprotectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT fanxiaomei theprotectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT maxiaochen theprotectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT liujiaming theprotectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT xuemingming theprotectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT wuxiaolong protectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT weiminghui protectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT zhanghaifeng protectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT fanxiaomei protectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT maxiaochen protectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT liujiaming protectiveeffectofaspirinagainstmyocardialhypertrophyinrats
AT xuemingming protectiveeffectofaspirinagainstmyocardialhypertrophyinrats